Delivery Order SPE2DB24D1007-SPE2DB25FCBKC

Award Date 4/22/25
Potential Completion Date 5/13/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price contract is for the delivery of the prescription medication Tagrisso 80 mg tablets. The contract has an ultimate completion date of May 12, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Tagrisso 80 mg tablet, with a ceiling value of $10,662.57 and a period of performance through May 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside and is open to full and open competition. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,903.03, is for the delivery of the prescription medication Tagrisso 80 mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,641.07, is for the delivery of the prescription medication Tagrisso 40 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not associated with a set-aside program and represents open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor in the United States. The contract is for the supply of the prescription drug Tagrisso 80 mg tablets, which are used to treat a specific type of non-small cell lung cancer. The contract has a ceiling value of $10,538.79 and runs through September 24, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Tagrisso 80 mg tablet in quantities of 30. The contract has a ceiling value of $63,141.30 and is a firm-fixed price contract. It has an ultimate completion date of October 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,662.57, is for the delivery of Tagrisso 80 mg tablets, a medication used in cancer treatment. The contract has a firm fixed price and an ultimate completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tagrisso (40 mg tablets). The contract has a ceiling value of $21,016.64 and an ultimate completion date of September 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Tagrisso 80 mg tablets, a specialty medication. The contract has a firm fixed price of $32,709.09 and a completion date of December 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a medication used to treat non-small cell lung cancer. The contract has a ceiling value of $10,662.57 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FCBKC
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Tagrisso 80 mg tablet in 30-count packages, with a total ceiling value of $10,662.57. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 13, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the larger IDC, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 7/22/25, 9:51 AM